Codexis signals transformation to full-service manufacturing innovator with ECO Synthesis platform and expects 2025 revenue at or above top end of guidance
Source: SeekingAlpha
2025-11-07 14:16:59 ET
More on Codexis
- Codexis, Inc. (CDXS) Q3 2025 Earnings Call Transcript
- Codexis, Inc. 2025 Q3 - Results - Earnings Call Presentation
- Codexis Weighs ECO Scale As Cash Runway Tightens
- Codexis reiterates $64M–$68M 2025 revenue guidance while exploring ECO Synthesis expansion
- Seeking Alpha’s Quant Rating on Codexis
Read the full article on Seeking Alpha
For further details see:
Codexis signals transformation to full-service manufacturing innovator with ECO Synthesis platform and expects 2025 revenue at or above top end of guidance
Codexis Inc.
NASDAQ: CDXS
CDXS Trading
2.47% G/L:
$1.245 Last:
492,064 Volume:
$1.23 Open:
CDXS Latest News
March 04, 2026 10:06:00 am
Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform
February 25, 2026 09:00:00 am
Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11
CDXS Stock Data
$116,066,832
79,756,430
0.15%
40
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
